About us

We are a leading ingredients company whose natural proteins and enzymes are the first choice across food, pharma, and feed industries. With a tradition of innovation spanning nearly 75 years, we aim to become the global market leader in catalysing the responsible development of proteins with our proprietary solvent-free processes. We are committed to R&D, knowing that scientific developments have led to our innovative portfolio of products, patents, and proprietary technologies.

At Bioseutica® we focus on the global supply of ultrapure bioactive proteins, extracting nature’s best from eggs and pancreas. Our egg-derived proteins are highly valued across broad industries that take inspiration from their roles in nature. Lysozyme, Avidin, and Ovotransferrin possess potent natural antimicrobial properties, utilised extensively across food processing, animal health, nutrition, hygiene, and pharmaceutical industries. Leveraging our expertise as global leaders in Lysozyme production, we have developed speciality formulations including the natural nootropic NA2R®, LYSOVIN for winemaking, LYSOLAC® for dairy, and the livestock immunity-boosting Entegard® range. Beyond the egg, we also extract digestive pancreatic enzymes including Trypsin, chymotrypsin, and Phospholipase A2. These have extensive applications in food processing, pharmaceutical, and medical research in applications requiring the faithful mimicking of natural digestive processes.

Our manufacturing processes are built on these high-end, cutting-edge proprietary technologies, allowing us to produce ingredients of the highest quality in our facilities across Canada and Europe. Our international reputation is built on the reliability of our quality and service.

Media

About Bioseutica®

Discover Bioseutica® the world-leading ingredients company from The Netherlands, who we are, our process, our commitment, and our production methodologies[...] 

Bioseutica® Food Ingredients

An overview of our natural food ingredients for clean label products. Bioseutica's enzymes and proteins are solvent and GMO-free to ensure the highest quality standard in food production[...] 

Bioseutica® NA2R®

NA2R® is a clinically proven natural ingredient for the novel food/nootropics industry. Its daily consumption leads to increased brain serotonin levels, exerting physiologically beneficial effects on the brain[...] 

Bioseutica®'s diversified range of products are sold to companies worldwide. In addition to this, Bioseutica® focuses on licensing-related intellectual property. Our organization enables us to efficiently deliver quality products, custom-designed solutions, and timely customer service to clients globally. Today, Bioseutica is the global leader in lysozyme1.

Our international management team strives to be on top of current consumer demands and industrial market trends worldwide.

Bioseutica®'s group of scientists and researchers are continuously developing innovative products for our food, feed, and pharmaceutical customers around the world, with a special focus on delivering the highest quality naturally sourced products. We apply our know-how and proprietary technology to transform natural commodities into highly concentrated active ingredients for industrial use. Our extensive manufacturing expertise allows us to produce high purity ingredients targeted to the high-quality segments of their respective markets.

Main business divisions:

  • Health
  • Nutrition
  • Research

Product lines:

  • Lysozyme (Muramidase)
  • Feed Additives
  • Egg Proteins
  • Proteases
  • Hydrolases
  • Specialties

Global Footprint

Note:

1. The origins of Bioseutica extend back to 1947 with the birth of PROSPA Pharmaceutical Companies, Solar Group, and SPA, (Società Prodotti Antibiotici), which formed the foundation of what is today Bioseutica. In 2007 the shareholders of Bioseutica acquired Neova Technologies Inc. and its plants in Europe and Canada, a company specializing in the development and production of natural proteins and pancreatic enzymes.

  LYSOZYME
Liquid
LYSOZYME
Granulated
LYSOZYME
Powder API
PROTEASE LIPASE EGG PROTEINS SPECIALTIES
Food              
Pharma              
Feed              
Cosmetics              
Diagnostics              
Cell Biology              
Industrial              
Molecular Biology              
Veterinary              
Nootropics              

Group Companies

Neova Technologies Inc. draws on almost thirty years of expertise in bioseparation and protein fractionation, building its international reputation on quality and service.

Neova takes an integrated approach to product development and quality enhancement. With a strong history in research and development to support the products we sell, our approach is to seek practical solutions that regularly challenge current limits and assumptions.

Neova’s strong team of researchers understands the functionality that our products can bring to the different industries and applications that our customers represent. Some research projects are undertaken with the objective of publication for the benefit of industry, while others are carried out for the benefit of a single customer. Regardless, the same systematic approach to the research applies. In addition, our customers are critical in establishing market needs and identifying opportunities. We take a collaborative approach and work with our customers to identify new products and applications.

Fordras, a Swiss company, has been serving the pharmaceutical and food industries since 1983. Fordras’ international experience in the sales of active pharmaceutical ingredients and food additives makes it one of the leading companies in the development, manufacturing and marketing of specialty, organic products such as Lysozyme. 

At Fordras, our mission is to develop, manufacture and sell natural products aimed at improving people’s health and at enhancing the way foods are processed and preserved. 

The company’s headquarters are located in Lugano, Switzerland. In 2012 Fordras has been integrated to the Bioseutica group. Bioseutica has manufacturing plants located in Denmark, Germany, Holland and Venezuela.

Healiva
healiva® is a Bioseutica backed innovative Swiss startup venture located in Lugano. It develops products for regenerative medicine.
 
healiva® uses a multi-pronged approach combining digital health, enzyme technology and cell therapy to address patient needs for repairing, rescuing or replacing damaged cells or tissues in their body. 
 
healiva® has core interests in innovating in cell therapy, enzyme technology, data analytics and medical devices to bring to the market products by accelerating the translation from bench-to-bedside. To provide patients and healthcare professionals with advanced products and therapies for regenerative medicine by leveraging on best in class innovations.